Published in Circulation on August 31, 1999
The effects of anaemia as a programming agent in the fetal heart. J Physiol (2005) 1.00
Up-regulation of soluble vascular endothelial growth factor receptor-1 prevents angiogenesis in hypertrophied myocardium. Cardiovasc Res (2010) 0.88
Hypoxic regulation of VEGF, HIF-1(alpha) in coronary collaterals development. Korean J Intern Med (2005) 0.76
Association of myocardial angiogenesis with structural and functional ventricular remodeling in aortic stenosis patients with normal ejection fraction. J Cardiovasc Ultrasound (2014) 0.75
Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc Natl Acad Sci U S A (1995) 4.33
Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background. J Clin Invest (1999) 3.38
A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat Genet (1995) 3.18
Guidelines for management of HIV infection with computer-based patient's record. Lancet (1995) 2.91
A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia. J Mol Cell Cardiol (2000) 2.70
Pepstatin, a new pepsin inhibitor produced by Actinomycetes. J Antibiot (Tokyo) (1970) 2.52
Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection. J Clin Invest (1998) 2.47
A specific, nonproliferative role for E2F-5 in choroid plexus function revealed by gene targeting. Genes Dev (1998) 2.19
Protection against mucoid Pseudomonas aeruginosa in rodent models of endobronchial infections. Science (1990) 2.03
High-risk behaviors during incarceration in African-American men treated for HIV at three Los Angeles public medical centers. J Acquir Immune Defic Syndr (2000) 2.00
Neonatal mouse model of group B streptococcal infection. J Infect Dis (1992) 1.82
The CH series of murine B cell lymphomas: neoplastic analogues of Ly-1+ normal B cells. Immunol Rev (1986) 1.81
Effect of pepstatin on acid proteases. J Antibiot (Tokyo) (1971) 1.75
Tumor necrosis factor-alpha and interleukin-1beta increase the Fas-mediated apoptosis of human osteoblasts. J Lab Clin Med (1999) 1.73
Restricted Ig variable region gene expression among Ly-1+ B cell lymphomas. J Immunol (1988) 1.72
Use of tibial length to quantify cardiac hypertrophy: application in the aging rat. Am J Physiol (1982) 1.72
Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes. J Antibiot (Tokyo) (1976) 1.66
Biased immunoglobulin variable region gene expression by Ly-1 B cells due to clonal selection. Eur J Immunol (1989) 1.52
Letter: A thermolysin inhibitor produced by Actinomycetes: phospholamidon. J Antibiot (Tokyo) (1973) 1.50
Antigen-induced lymphomagenesis: identification of a murine B cell lymphoma with known antigen specificity. J Immunol (1983) 1.49
Normal and hypertrophic growth of the rat heart: changes in cell dimensions and number. Am J Physiol (1978) 1.43
Phosphatidyl choline is recognized by a series of Ly-1+ murine B cell lymphomas specific for erythrocyte membranes. J Exp Med (1986) 1.43
High frequency expression of S107 VH genes by peritoneal B cells of B10.H-2aH-4bP/WTS mice. J Immunol (1990) 1.43
Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy. Clin Infect Dis (2006) 1.42
Blood volume measurement at the bedside using ICG pulse spectrophotometry. Anesthesiology (1998) 1.37
Biological activities of leupeptins. J Antibiot (Tokyo) (1969) 1.33
Dextran sulphate: an adjuvant for cell-mediated immune responses. Immunology (1977) 1.33
B-1 cells are made, not born. Immunol Today (1993) 1.32
Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butylmethacrylate). J Control Release (1999) 1.30
Regulation of thyroid hormone receptor isoforms in physiological and pathological cardiac hypertrophy. Circ Res (2001) 1.30
Leupeptins, new protease inhibitors from Actinomycetes. J Antibiot (Tokyo) (1969) 1.29
Folliculosebaceous cystic hamartoma. A distinctive malformation of the skin. Am J Dermatopathol (1991) 1.29
DNA repair methyltransferase (Mgmt) knockout mice are sensitive to the lethal effects of chemotherapeutic alkylating agents. Mutagenesis (1999) 1.28
Metabolic cooperation between vascular endothelial cells and smooth muscle cells in co-culture: changes in low density lipoprotein metabolism. J Cell Biol (1985) 1.27
Biological activity of pepstatins, pepstanone A and partial peptides on pepsin, cathepsin D and renin. J Antibiot (Tokyo) (1972) 1.26
Transplantable B-cell lymphomas in B10. H-2aH-4bp/Wts mice. Immunogenetics (1982) 1.23
The growth of the muscular and collagenous parts of the rat heart in various forms of cardiomegaly. J Physiol (1969) 1.22
Antipain, a new protease inhibitor isolated from actinomycetes. J Antibiot (Tokyo) (1972) 1.21
Serum amyloid A protein induces production of matrix metalloproteinases by human synovial fibroblasts. Lab Invest (1998) 1.20
Analysis of human T cell clones specific for conserved peptide sequences within malaria proteins. Paucity of clones responsive to intact parasites. J Immunol (1994) 1.20
Restricted immunoglobulin variable region gene usage by normal Ly-1 (CD5+) B cells that recognize phosphatidyl choline. J Exp Med (1989) 1.20
Effect of protease inhibitors of actinomycetes on lysosomal peptide-hydrolases from swine liver. J Antibiot (Tokyo) (1971) 1.19
The effect of bile acids and renal ischemia on renal function. J Lab Clin Med (1968) 1.19
High frequency of malaria-specific T cells in non-exposed humans. Eur J Immunol (1992) 1.17
Loss of high affinity cardiac beta adrenergic receptors in dogs with heart failure. J Clin Invest (1985) 1.16
The structure of pepstatin. J Antibiot (Tokyo) (1970) 1.15
Nitric oxide-mediated effects of interleukin-6 on [Ca2+]i and cell contraction in cultured chick ventricular myocytes. Circ Res (1994) 1.15
Cardiac output and circulating blood volume analysis by pulse dye-densitometry. J Clin Monit (1997) 1.14
Immunohistological analysis of memory T lymphocytes and activated B lymphocytes in tissues with periodontal disease. J Periodontal Res (1993) 1.13
Chymostatin, a new chymotrypsin inhibitor produced by actinomycetes. J Antibiot (Tokyo) (1970) 1.10
'Original antigenic sin', T cell memory, and malaria sporozoite immunity: an hypothesis for immune evasion. Parasite Immunol (1993) 1.08
B-1 cell development: evidence for an uncommitted immunoglobulin (Ig)M+ B cell precursor in B-1 cell differentiation. J Exp Med (1998) 1.06
Calcineurin is activated in rat hearts with physiological left ventricular hypertrophy induced by voluntary exercise training. Circulation (2000) 1.06
Production of actinonin, an inhibitor of aminopeptidase M, by actinomycetes. J Antibiot (Tokyo) (1985) 1.04
A model for intracellular energy transport. Can J Physiol Pharmacol (1982) 1.03
Amastatin, an inhibitor of aminopeptidase A, produced by actinomycetes. J Antibiot (Tokyo) (1978) 1.03
Comparative studies of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudine. AIDS (2000) 1.03
Purification by affinity chromatography using amastatin and properties of aminopeptidase A from pig kidney. Biochim Biophys Acta (1980) 1.02
Fibroblast growth factors released by wounded endothelial cells stimulate proliferation of synovial cells. J Rheumatol (1992) 1.02
Phenotype of B cells responding to the thymus-independent type-2 antigen polyvinyl pyrrolidinone. Int Immunol (1996) 1.02
Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by C1 inhibitor replacement. J Immunol (1997) 1.02
Antiphencyclidine monoclonal Fab fragments reverse phencyclidine-induced behavioral effects and ataxia in rats. J Pharmacol Exp Ther (1996) 1.01
Cross-reactive idiotypes and common antigen binding specificities expressed by a series of murine B-cell lymphomas: etiological implications. Proc Natl Acad Sci U S A (1985) 1.01
Synthesis and structure-activity relationships of bestatin analogues, inhibitors of aminopeptidase B. J Med Chem (1977) 1.01
An enzyme inhibitor, panosialin, produced by Streptomyces. II. Chemistry of panosialin, 5-alkylbenzene-1,3-disulfates. J Antibiot (Tokyo) (1971) 1.00
Myocardial angiogenesis and coronary perfusion in left ventricular pressure-overload hypertrophy in the young lamb. Evidence for inhibition with chronic protamine administration. Circ Res (1991) 0.99
Cutaneous inflammatory disorder in integrin alphaE (CD103)-deficient mice. J Immunol (2000) 0.99
Quantitative morphology of capillaries of the heart. Number of capillaries in animal and human hearts under normal and pathological conditions. Methods Achiev Exp Pathol (1971) 0.99
TNF-alpha-mediated expression of membrane-type matrix metalloproteinase in rheumatoid synovial fibroblasts. Immunology (1996) 0.99
Plipastatins: new inhibitors of phospholipase A2, produced by Bacillus cereus BMG302-fF67. I. Taxonomy, production, isolation and preliminary characterization. J Antibiot (Tokyo) (1986) 0.98
Laparoscopic heminephrectomy of a horseshoe kidney using microwave coagulator. J Urol (1999) 0.98
Measurement of plasma brain natriuretic peptide level as a guide for cardiac overload. Cardiovasc Res (2001) 0.96
Effect of molecular architecture of hydrophobically modified poly(N-isopropylacrylamide) on the formation of thermoresponsive core-shell micellar drug carriers. J Control Release (1998) 0.96
Inhibition of Fas antigen-mediated apoptosis of rheumatoid synovial cells in vitro by transforming growth factor beta 1. Arthritis Rheum (1996) 0.96
Epinephrine-induced cyclic AMP accumulation in the psoriatic epidermis. Acta Derm Venereol (1981) 0.96
Plipastatins: new inhibitors of phospholipase A2, produced by Bacillus cereus BMG302-fF67. II. Structure of fatty acid residue and amino acid sequence. J Antibiot (Tokyo) (1986) 0.96
Studies on inhibitory effect of phosphoramidon and its analogs on thermolysin. Arch Biochem Biophys (1975) 0.96
Capacity of the terminal vascular bed during normal growth, in cardiomegaly, and in cardiac atrophy. Circ Res (1967) 0.95
Direct and indirect effects of Porphyromonas gingivalis lipopolysaccharide on interleukin-6 production by human gingival fibroblasts. Oral Microbiol Immunol (1992) 0.95
Inhibitory effect of clarithromycin on costimulatory molecule expression and cytokine production by synovial fibroblast-like cells. Clin Exp Immunol (1996) 0.94
Diprotins A and B, inhibitors of dipeptidyl aminopeptidase IV, produced by bacteria. J Antibiot (Tokyo) (1984) 0.94
ASKP1240, a fully human anti-CD40 monoclonal antibody, prolongs pancreatic islet allograft survival in nonhuman primates. Am J Transplant (2013) 0.94
Remodeling of myocyte dimensions in hypertrophic and atrophic rat hearts. Circ Res (1991) 0.94
The structure of bestatin. J Antibiot (Tokyo) (1976) 0.94
Inhibition of Plasmodium falciparum growth in vitro by CD4+ and CD8+ T cells from non-exposed donors. Parasite Immunol (1994) 0.94
Letter: Elastatinal, a new elastase inhibitor produced by actinomycetes. J Antibiot (Tokyo) (1973) 0.94
Plipastatins: new inhibitors of phospholipase A2, produced by Bacillus cereus BMG302-fF67. III. Structural elucidation of plipastatins. J Antibiot (Tokyo) (1986) 0.94
Invariant or highly conserved TCR alpha are expressed on double-negative (CD3+CD4-CD8-) and CD8+ T cells. J Immunol (1999) 0.94
Regional capillary supply in the normal and hypertrophied rat heart. Microvasc Res (1980) 0.94
Inhibition of aminopeptidase B and leucine aminopeptidase by bestatin and its stereoisomer. Arch Biochem Biophys (1976) 0.94
Aminopeptidase activities on the surface of mammalian cells. Biochim Biophys Acta (1976) 0.94
Galactosialidosis (beta-galactosidase-neuraminidase deficiency): a possible role of serine-thiol proteases in the degradation of beta-galactosidase molecules. Clin Chim Acta (1982) 0.94
Inhibitory effects of phosphoramidon on neutral metalloendopeptidases and its application on affinity chromatography. Biochem Biophys Res Commun (1975) 0.93
Functional capillary density in normal and transplanted rat hearts. Can J Physiol Pharmacol (1982) 0.93
Anti-phencyclidine monoclonal Fab fragments markedly alter phencyclidine pharmacokinetics in rats. J Pharmacol Exp Ther (1994) 0.93
Induced differentiation of a B cell lymphoma with known antigen specificity. J Mol Cell Immunol (1984) 0.92
Increased population of high fluorescence 1F7 (CD26) antigen on T cells in synovial fluid of patients with rheumatoid arthritis. J Rheumatol (1996) 0.92
Role of cell surface immunoglobulin in B-lymphocyte activation. Proc Natl Acad Sci U S A (1984) 0.92
The effect of cell size and capillary spacing on myocardial oxygen supply. Adv Exp Med Biol (1984) 0.92